Article

Sorafenib inhibits invasion of multicellular organoids that mimic Lymphangioleiomyomatosis…

medRxiv · 2023 · Koc-Gunel, S.; Gautam, L. K.; Calvert, B. A.; Murthy, S.; Harriott, N. C.; Nawroth, J. C.; Zhou, B.; Krymskaya, V. P.; Ryan, A. L.

Key facts

Title Sorafenib inhibits invasion of multicellular organoids that mimic Lymphangioleiomyomatosis nodules.
First author Koc-Gunel, S.; Gautam, L. K.; Calvert, B. A.; Murthy, S.; Harriott, N. C.; Nawroth, J. C.; Zhou, B.; Krymskaya, V. P.; Ryan, A. L.
Journal medRxiv
Published Jun 12, 2023
DOI 10.1101/2023.06.12.544372
Product codes mentioned JJH, KIP, KIT, LEA, PFF, PFT, PPM

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature